Onsior (2.5 - 6 kg)
Active substance
ATC code
Species
Cats
Indications
For the treatment of pain and inflammation associated with acute or chronic musculoskeletal disorders in cats.
For the reduction of moderate pain and inflammation associated with orthopaedic surgery in cats.
Dose to be administered and administration route
For oral use.
Give either without food or with a small amount of food. The tablets are easy to administer and well accepted by most cats. The tablets should not be divided or broken.
The recommended dose of robenacoxib is 1 mg/kg body weight with a range 1– 2.4 mg/kg. The following number of tablets should be given once daily at the same time every day:
|
Body weight (kg) |
Number of tablets |
|
2.5 to < 6 |
1 tablet |
|
6 to 12 |
2 tablets |
Acute musculoskeletal disorders: treat for up to 6 days.
Chronic musculoskeletal disorders: Duration of treatment should be decided on an individual basis. Please refer to section 4.5.
A clinical response is normally seen within 3-6 weeks. Treatment should be discontinued after 6 weeks if no clinical improvement is apparent.
Orthopaedic surgery: Give as a single oral treatment prior to orthopaedic surgery.
Premedication should only be carried out in combination with butorphanolanalgesia. The tablet(s) should be administered without food at least 30 minutes prior to surgery.
After surgery, once daily treatment may be continued for up to two further days. If necessary, additional analgesic treatment with opioids is recommended.
The interchangeable use of Onsior tablets and Onsior solution for injection has been tested in a target animal safety study and was shown to be well tolerated by cats.
For cats, Onsior solution for injection or tablets may be used interchangeably in accordance with the indications and directions of use approved for each pharmaceutical form. Treatment should not exceed one dose (either tablet or injection) per day. Please note that the recommended doses for the two formulations are different.
Adverse reactions
Target species: Cats
|
Common (1 to 10 animals / 100 animals treated): |
Diarrhoea1, Vomiting1 |
|
Very rare (< 1 animal / 10,000 animals treated, including isolated reports): |
Elevated renal parameters (creatinine, BUN, and SDMA)2 Renal insufficiency2 Lethargy |
Mild and transient.2 More commonly in older cats and with concomitant use of anaesthetic or sedative agents (
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See also the last section of the package leaflet for contact details.
| PRICE | Only for registered vets. Create a free profile to access all features.. Login |
|---|---|
| Art. Nr. | 52127/5024 |
| EAN | 5037694046637 |
